{"transactions":[{"id":765450,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2026-05-22T23:58:06.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":5409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This amendment is being filed to reflect the vesting terms applicable to this award, which were reported incorrectly on the original Form 4. The correct vesting schedule is set forth in Footnote 1 above."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This amendment is being filed to reflect the vesting terms applicable to this award, which were reported incorrectly on the original Form 4. The correct vesting schedule is set forth in Footnote 1 above."}],"balance_after":5409,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5409},"source":{"system":"sec-edgar","filing":"0001520262-26-000086","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000086/form4a.xml","form_type":"4/A","original_submission_date":"2026-05-22"}},{"id":765449,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2026-05-22T23:58:06.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":11538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This amendment is being filed to reflect the vesting terms applicable to this award, which were reported incorrectly on the original Form 4. The correct vesting schedule is set forth in Footnote 1 above."}],"balance_after":11538,"derivative":{"exercise_price":36.98,"expiration_date":"2036-05-20","underlying":"Ordinary Shares","underlying_shares":11538},"source":{"system":"sec-edgar","filing":"0001520262-26-000086","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000086/form4a.xml","form_type":"4/A","original_submission_date":"2026-05-22"}},{"id":765447,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2026-05-22T20:57:44.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":false,"shares":6142,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This award is fully vested in accordance with its terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This award is fully vested in accordance with its terms."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6142},"source":{"system":"sec-edgar","filing":"0001520262-26-000083","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000083/form4.xml","form_type":"4"}},{"id":765446,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2026-05-22T20:57:44.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":5409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in full on 5/20/2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in full on 5/20/2027."}],"balance_after":5409,"derivative":{"exercise_date":"2027-05-20","underlying":"Ordinary Shares","underlying_shares":5409},"source":{"system":"sec-edgar","filing":"0001520262-26-000083","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000083/form4.xml","form_type":"4"}},{"id":765445,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2026-05-22T20:57:44.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":11538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the stock option award vest and become exercisable in full on 5/20/2027."}],"balance_after":11538,"derivative":{"exercise_price":36.98,"exercise_date":"2027-05-20","expiration_date":"2036-05-20","underlying":"Ordinary Shares","underlying_shares":11538},"source":{"system":"sec-edgar","filing":"0001520262-26-000083","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000083/form4.xml","form_type":"4"}},{"id":765444,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-05-22T20:57:44.000Z","date":"2026-05-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":3207,"price":36.95,"value":118498.65,"ownership":{"direct":true},"balance_after":106679,"source":{"system":"sec-edgar","filing":"0001520262-26-000083","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000083/form4.xml","form_type":"4"}},{"id":765443,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-05-22T20:57:44.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":true,"shares":6142,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":109886,"source":{"system":"sec-edgar","filing":"0001520262-26-000083","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000083/form4.xml","form_type":"4"}},{"id":776726,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-16T01:28:14.000Z","date":"2026-05-15","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2027 of the Issuer's shareholders, assuming continuous service as a director until such vesting date."}],"balance_after":27000,"derivative":{"exercise_price":9.76,"expiration_date":"2036-05-15","underlying":"Ordinary Shares","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0000905148-26-002467","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000090514826002467/form4.xml","form_type":"4"}},{"id":924565,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-02-03T01:48:51.000Z","date":"2026-02-02","kind":"exercise","planned":true,"acquired":false,"shares":61200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and sale of expiring options was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/27/25."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested in accordance with their terms."}],"balance_after":0,"derivative":{"exercise_price":31.64,"expiration_date":"2026-02-28","underlying":"Ordinary Shares","underlying_shares":61200},"source":{"system":"sec-edgar","filing":"0001520262-26-000008","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000008/form4.xml","form_type":"4"}},{"id":924564,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-02-03T01:48:51.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":32113,"price":34.7796,"value":1116877.2948,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and sale of expiring options was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/27/25."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.70 to $34.91. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":103744,"source":{"system":"sec-edgar","filing":"0001520262-26-000008","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000008/form4.xml","form_type":"4"}},{"id":924563,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-02-03T01:48:51.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":29087,"price":34.3382,"value":998795.2234,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and sale of expiring options was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/27/25."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.6923 to $34.69. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":135857,"source":{"system":"sec-edgar","filing":"0001520262-26-000008","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000008/form4.xml","form_type":"4"}},{"id":924562,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-02-03T01:48:51.000Z","date":"2026-02-02","kind":"exercise","planned":true,"acquired":true,"shares":61200,"price":31.64,"value":1936368.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and sale of expiring options was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/27/25."}],"balance_after":164944,"source":{"system":"sec-edgar","filing":"0001520262-26-000008","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000008/form4.xml","form_type":"4"}},{"id":1127257,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2025-06-02T20:28:57.000Z","date":"2025-05-31","kind":"exercise","planned":false,"acquired":false,"shares":8013,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award is fully vested in accordance with its terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award is fully vested in accordance with its terms."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8013},"source":{"system":"sec-edgar","filing":"0001127602-25-016196","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225016196/form4.xml","form_type":"4"}},{"id":1127256,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2025-06-02T20:28:57.000Z","date":"2025-05-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":4175,"price":30.61,"value":127796.75,"ownership":{"direct":true},"balance_after":103744,"source":{"system":"sec-edgar","filing":"0001127602-25-016196","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225016196/form4.xml","form_type":"4"}},{"id":1127255,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2025-06-02T20:28:57.000Z","date":"2025-05-31","kind":"exercise","planned":false,"acquired":true,"shares":8013,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":107919,"source":{"system":"sec-edgar","filing":"0001127602-25-016196","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225016196/form4.xml","form_type":"4"}},{"id":1134835,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2025-05-23T21:55:20.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":6142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in full on 5/21/2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in full on 5/21/2026."}],"balance_after":6142,"derivative":{"exercise_date":"2026-05-21","underlying":"Ordinary Shares","underlying_shares":6142},"source":{"system":"sec-edgar","filing":"0001127602-25-015538","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225015538/form4.xml","form_type":"4"}},{"id":1134834,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2025-05-23T21:55:20.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":13474,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the stock option award vest and become exercisable in full on 5/21/2026."}],"balance_after":13474,"derivative":{"exercise_price":30.53,"exercise_date":"2026-05-21","expiration_date":"2035-05-21","underlying":"Ordinary Shares","underlying_shares":13474},"source":{"system":"sec-edgar","filing":"0001127602-25-015538","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225015538/form4.xml","form_type":"4"}},{"id":1144899,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-16T20:47:33.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":20183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2026 of the Issuer's shareholders, assuming continuous service as a director until such vesting date."}],"balance_after":20183,"derivative":{"exercise_price":6.885,"expiration_date":"2035-05-14","underlying":"Ordinary Shares","underlying_shares":20183},"source":{"system":"sec-edgar","filing":"0000905148-25-001829","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000090514825001829/form4.xml","form_type":"4"}},{"id":1465514,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2024-07-01T20:52:28.000Z","date":"2024-06-29","kind":"exercise","planned":false,"acquired":false,"shares":6104,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award is fully vested in accordance with its terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award is fully vested in accordance with its terms."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6104},"source":{"system":"sec-edgar","filing":"0001127602-24-019585","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760224019585/form4.xml","form_type":"4"}},{"id":1465513,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2024-07-01T20:52:28.000Z","date":"2024-06-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":3175,"price":24.1,"value":76517.5,"ownership":{"direct":true},"balance_after":99906,"source":{"system":"sec-edgar","filing":"0001127602-24-019585","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760224019585/form4.xml","form_type":"4"}},{"id":1465512,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2024-07-01T20:52:28.000Z","date":"2024-06-29","kind":"exercise","planned":false,"acquired":true,"shares":6104,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":103081,"source":{"system":"sec-edgar","filing":"0001127602-24-019585","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760224019585/form4.xml","form_type":"4"}},{"id":1491540,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2024-06-04T20:49:22.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":17492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Shares subject to the stock option award vest and become exercisable in full on 5/31/2025."}],"balance_after":17492,"derivative":{"exercise_price":23.4,"exercise_date":"2025-05-31","expiration_date":"2034-05-31","underlying":"Ordinary Shares","underlying_shares":17492},"source":{"system":"sec-edgar","filing":"0001127602-24-017716","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760224017716/form4.xml","form_type":"4"}},{"id":1491539,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2024-06-04T20:49:22.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":8013,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Shares subject to the restricted stock unit award vest in full on 5/31/2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Shares subject to the restricted stock unit award vest in full on 5/31/2025."}],"balance_after":8013,"derivative":{"exercise_date":"2025-05-31","underlying":"Ordinary Shares","underlying_shares":8013},"source":{"system":"sec-edgar","filing":"0001127602-24-017716","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760224017716/form4.xml","form_type":"4"}},{"id":1491538,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2024-06-04T20:49:22.000Z","date":"2023-11-17","kind":"other","planned":false,"acquired":true,"shares":119,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the \"Separation\"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares subject to the restricted stock unit award vest in full on 6/29/2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Shares subject to the restricted stock unit award vest in full on 6/29/2024."}],"balance_after":6104,"derivative":{"exercise_date":"2024-06-29","underlying":"Ordinary Shares","underlying_shares":119},"source":{"system":"sec-edgar","filing":"0001127602-24-017716","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760224017716/form4.xml","form_type":"4"}},{"id":1491537,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2024-06-04T20:49:22.000Z","date":"2023-11-17","kind":"other","planned":false,"acquired":true,"shares":254,"price":30.72,"value":7802.88,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the \"Separation\"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the stock option award vest and become exercisable in full on 6/29/2024."}],"balance_after":12986,"derivative":{"exercise_price":30.72,"exercise_date":"2024-06-29","expiration_date":"2033-06-29","underlying":"Ordinary Shares","underlying_shares":254},"source":{"system":"sec-edgar","filing":"0001127602-24-017716","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760224017716/form4.xml","form_type":"4"}},{"id":1491536,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2024-06-04T20:49:22.000Z","date":"2023-11-17","kind":"other","planned":false,"acquired":true,"shares":231,"price":30.86,"value":7128.66,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the \"Separation\"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested in accordance with their terms."}],"balance_after":11785,"derivative":{"exercise_price":30.86,"expiration_date":"2032-07-07","underlying":"Ordinary Shares","underlying_shares":231},"source":{"system":"sec-edgar","filing":"0001127602-24-017716","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760224017716/form4.xml","form_type":"4"}},{"id":1491535,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2024-06-04T20:49:22.000Z","date":"2023-11-17","kind":"other","planned":false,"acquired":true,"shares":313,"price":24.24,"value":7587.12,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the \"Separation\"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested in accordance with their terms."}],"balance_after":15990,"derivative":{"exercise_price":24.24,"expiration_date":"2031-06-14","underlying":"Ordinary Shares","underlying_shares":313},"source":{"system":"sec-edgar","filing":"0001127602-24-017716","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760224017716/form4.xml","form_type":"4"}},{"id":1491534,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2024-06-04T20:49:22.000Z","date":"2023-11-17","kind":"other","planned":false,"acquired":true,"shares":230,"price":18.45,"value":4243.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the \"Separation\"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested in accordance with their terms."}],"balance_after":11739,"derivative":{"exercise_price":18.45,"expiration_date":"2030-12-02","underlying":"Ordinary Shares","underlying_shares":230},"source":{"system":"sec-edgar","filing":"0001127602-24-017716","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760224017716/form4.xml","form_type":"4"}},{"id":1491533,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2024-06-04T20:49:22.000Z","date":"2023-11-17","kind":"other","planned":false,"acquired":true,"shares":256,"price":16.52,"value":4229.12,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the \"Separation\"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested in accordance with their terms."}],"balance_after":13079,"derivative":{"exercise_price":16.52,"expiration_date":"2030-05-20","underlying":"Ordinary Shares","underlying_shares":256},"source":{"system":"sec-edgar","filing":"0001127602-24-017716","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760224017716/form4.xml","form_type":"4"}},{"id":1491532,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2024-06-04T20:49:22.000Z","date":"2023-11-17","kind":"other","planned":false,"acquired":true,"shares":448,"price":24.55,"value":10998.4,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the \"Separation\"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested in accordance with their terms."}],"balance_after":22848,"derivative":{"exercise_price":24.55,"expiration_date":"2029-05-22","underlying":"Ordinary Shares","underlying_shares":448},"source":{"system":"sec-edgar","filing":"0001127602-24-017716","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760224017716/form4.xml","form_type":"4"}},{"id":1491531,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2024-06-04T20:49:22.000Z","date":"2023-11-17","kind":"other","planned":false,"acquired":true,"shares":350,"price":44.75,"value":15662.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the \"Separation\"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested in accordance with their terms."}],"balance_after":17850,"derivative":{"exercise_price":44.75,"expiration_date":"2028-05-23","underlying":"Ordinary Shares","underlying_shares":350},"source":{"system":"sec-edgar","filing":"0001127602-24-017716","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760224017716/form4.xml","form_type":"4"}},{"id":1491530,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2024-06-04T20:49:22.000Z","date":"2023-11-17","kind":"other","planned":false,"acquired":true,"shares":520,"price":44.75,"value":23270.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the \"Separation\"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested in accordance with their terms."}],"balance_after":26520,"derivative":{"exercise_price":44.75,"expiration_date":"2028-05-23","underlying":"Ordinary Shares","underlying_shares":520},"source":{"system":"sec-edgar","filing":"0001127602-24-017716","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760224017716/form4.xml","form_type":"4"}},{"id":1491529,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-06-04T20:49:22.000Z","date":"2023-11-17","kind":"other","planned":false,"acquired":true,"shares":425,"price":53.5,"value":22737.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the \"Separation\"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested in accordance with their terms."}],"balance_after":21675,"derivative":{"exercise_price":53.5,"expiration_date":"2027-02-17","underlying":"Ordinary Shares","underlying_shares":425},"source":{"system":"sec-edgar","filing":"0001127602-24-017716","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760224017716/form4.xml","form_type":"4"}},{"id":1491528,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-06-04T20:49:22.000Z","date":"2023-11-17","kind":"other","planned":false,"acquired":true,"shares":1200,"price":31.64,"value":37968.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the \"Separation\"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested in accordance with their terms."}],"balance_after":61200,"derivative":{"exercise_price":31.64,"expiration_date":"2026-02-28","underlying":"Ordinary Shares","underlying_shares":1200},"source":{"system":"sec-edgar","filing":"0001127602-24-017716","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760224017716/form4.xml","form_type":"4"}},{"id":1491527,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-06-04T20:49:22.000Z","date":"2023-11-17","kind":"other","planned":false,"acquired":true,"shares":1102,"price":69.83,"value":76952.66,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the \"Separation\"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested in accordance with their terms."}],"balance_after":56227,"derivative":{"exercise_price":69.83,"expiration_date":"2025-02-26","underlying":"Ordinary Shares","underlying_shares":1102},"source":{"system":"sec-edgar","filing":"0001127602-24-017716","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760224017716/form4.xml","form_type":"4"}},{"id":1510641,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-17T20:35:10.000Z","date":"2024-05-15","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2025 of the Issuer's shareholders, assuming continuous service as a director until such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":22.39,"expiration_date":"2034-05-15","underlying":"Ordinary Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000905148-24-001532","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000090514824001532/form4.xml","form_type":"4"}},{"id":1832095,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2023-07-11T00:27:33.000Z","date":"2023-07-07","kind":"exercise","planned":false,"acquired":false,"shares":5957,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award is fully vested in accordance with its terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award is fully vested in accordance with its terms."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5957},"source":{"system":"sec-edgar","filing":"0001127602-23-020545","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760223020545/form4.xml","form_type":"4"}},{"id":1832094,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2023-07-11T00:27:33.000Z","date":"2023-07-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":3098,"price":29.88,"value":92568.24,"ownership":{"direct":true},"balance_after":96977,"source":{"system":"sec-edgar","filing":"0001127602-23-020545","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760223020545/form4.xml","form_type":"4"}},{"id":1832093,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2023-07-11T00:27:33.000Z","date":"2023-07-07","kind":"exercise","planned":false,"acquired":true,"shares":5957,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":100075,"source":{"system":"sec-edgar","filing":"0001127602-23-020545","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760223020545/form4.xml","form_type":"4"}},{"id":1840852,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2023-06-30T20:31:00.000Z","date":"2023-06-29","kind":"grant","planned":false,"acquired":true,"shares":5985,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in full on 6/29/2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in full on 6/29/2024."}],"balance_after":5985,"derivative":{"exercise_date":"2024-06-29","underlying":"Ordinary Shares","underlying_shares":5985},"source":{"system":"sec-edgar","filing":"0001127602-23-019624","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760223019624/form4.xml","form_type":"4"}},{"id":1840851,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2023-06-30T20:31:00.000Z","date":"2023-06-29","kind":"grant","planned":false,"acquired":true,"shares":12732,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the stock option award vest and become exercisable in full on 6/29/2024."}],"balance_after":12732,"derivative":{"exercise_price":31.33,"exercise_date":"2024-06-29","expiration_date":"2033-06-29","underlying":"Ordinary Shares","underlying_shares":12732},"source":{"system":"sec-edgar","filing":"0001127602-23-019624","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760223019624/form4.xml","form_type":"4"}},{"id":1884171,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-20T01:31:27.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2024 of the Issuer's shareholders, assuming continuous service as a director until such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":76,"expiration_date":"2033-05-17","underlying":"Ordinary Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001140361-23-025832","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000114036123025832/form4.xml","form_type":"4"}},{"id":2055447,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-13T02:31:36.000Z","date":"2023-01-10","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option would have expired in approximately one month and would have been forfeited to the extent it was not exercised on or prior to January 29, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option would have expired in approximately one month and would have been forfeited to the extent it was not exercised on or prior to January 29, 2023."}],"balance_after":0,"derivative":{"exercise_price":6.41,"exercise_date":"2014-01-29","expiration_date":"2023-01-29","underlying":"Ordinary Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001567619-23-000905","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000156761923000905/doc1.xml","form_type":"4"}},{"id":2055446,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-01-13T02:31:36.000Z","date":"2023-01-10","kind":"sale","acquired":false,"shares":5000,"price":52.9216,"value":264608.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $52.28 to $53.175, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnote 2 of this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-23-000905","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000156761923000905/doc1.xml","form_type":"4"}},{"id":2055445,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2023-01-13T02:31:36.000Z","date":"2023-01-10","kind":"exercise","acquired":true,"shares":5000,"price":6.41,"value":32050.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001567619-23-000905","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000156761923000905/doc1.xml","form_type":"4"}},{"id":2089379,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-13T02:31:10.000Z","date":"2022-12-12","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately two months and be forfeited to the extent it is not exercised on or prior to January 29, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately two months and be forfeited to the extent it is not exercised on or prior to January 29, 2023."}],"balance_after":5000,"derivative":{"exercise_price":6.41,"exercise_date":"2014-01-29","expiration_date":"2023-01-29","underlying":"Ordinary Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001567619-22-021514","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000156761922021514/doc1.xml","form_type":"4"}},{"id":2089378,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-12-13T02:31:10.000Z","date":"2022-12-12","kind":"sale","acquired":false,"shares":3887,"price":61.4113,"value":238705.7231,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $60.72 to $61.55, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-22-021514","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000156761922021514/doc1.xml","form_type":"4"}},{"id":2089377,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-12-13T02:31:10.000Z","date":"2022-12-12","kind":"sale","acquired":false,"shares":781,"price":60.0781,"value":46920.9961,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $59.68 to $60.57, inclusive."}],"balance_after":3887,"source":{"system":"sec-edgar","filing":"0001567619-22-021514","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000156761922021514/doc1.xml","form_type":"4"}},{"id":2089376,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-12-13T02:31:10.000Z","date":"2022-12-12","kind":"sale","acquired":false,"shares":332,"price":58.9295,"value":19564.594,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $58.425 to $59.32, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the ranges set forth in footnotes 2 through 4 of this Form 4."}],"balance_after":4668,"source":{"system":"sec-edgar","filing":"0001567619-22-021514","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000156761922021514/doc1.xml","form_type":"4"}},{"id":2089375,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-12-13T02:31:10.000Z","date":"2022-12-12","kind":"exercise","acquired":true,"shares":5000,"price":6.41,"value":32050.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001567619-22-021514","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000156761922021514/doc1.xml","form_type":"4"}},{"id":2119792,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-11T02:30:32.000Z","date":"2022-11-10","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately three months and be forfeited to the extent it is not exercised on or prior to January 29, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately three months and be forfeited to the extent it is not exercised on or prior to January 29, 2023."}],"balance_after":10000,"derivative":{"exercise_price":6.41,"exercise_date":"2014-01-29","expiration_date":"2023-01-29","underlying":"Ordinary Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001567619-22-019628","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000156761922019628/doc1.xml","form_type":"4"}},{"id":2119791,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-11-11T02:30:32.000Z","date":"2022-11-10","kind":"sale","acquired":false,"shares":875,"price":56.8518,"value":49745.325,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $56.52 to $57.12, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-22-019628","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000156761922019628/doc1.xml","form_type":"4"}},{"id":2119790,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-11-11T02:30:32.000Z","date":"2022-11-10","kind":"sale","acquired":false,"shares":3870,"price":56.1402,"value":217262.574,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $55.51 to $56.50, inclusive."}],"balance_after":875,"source":{"system":"sec-edgar","filing":"0001567619-22-019628","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000156761922019628/doc1.xml","form_type":"4"}},{"id":2119789,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-11-11T02:30:32.000Z","date":"2022-11-10","kind":"sale","acquired":false,"shares":255,"price":54.1951,"value":13819.7505,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $54.005 to $55.00, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the ranges set forth in footnotes 2 through 4 of this Form 4."}],"balance_after":4745,"source":{"system":"sec-edgar","filing":"0001567619-22-019628","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000156761922019628/doc1.xml","form_type":"4"}},{"id":2119788,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-11-11T02:30:32.000Z","date":"2022-11-10","kind":"exercise","acquired":true,"shares":5000,"price":6.41,"value":32050.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001567619-22-019628","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000156761922019628/doc1.xml","form_type":"4"}},{"id":2138145,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-13T01:45:24.000Z","date":"2022-10-10","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately four months and be forfeited to the extent it is not exercised on or prior to January 29, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately four months and be forfeited to the extent it is not exercised on or prior to January 29, 2023."}],"balance_after":15000,"derivative":{"exercise_price":6.41,"exercise_date":"2014-01-29","expiration_date":"2023-01-29","underlying":"Ordinary Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001567619-22-018466","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000156761922018466/doc1.xml","form_type":"4"}},{"id":2138144,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-10-13T01:45:24.000Z","date":"2022-10-10","kind":"sale","acquired":false,"shares":2676,"price":56.3786,"value":150869.1336,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $56.01 to $56.96, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-22-018466","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000156761922018466/doc1.xml","form_type":"4"}},{"id":2138143,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-10-13T01:45:24.000Z","date":"2022-10-10","kind":"sale","acquired":false,"shares":2324,"price":55.3705,"value":128681.042,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $54.855 to $55.85, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the ranges set forth in footnotes 2 and 3 of this Form 4."}],"balance_after":2676,"source":{"system":"sec-edgar","filing":"0001567619-22-018466","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000156761922018466/doc1.xml","form_type":"4"}},{"id":2138142,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-10-13T01:45:24.000Z","date":"2022-10-10","kind":"exercise","acquired":true,"shares":5000,"price":6.41,"value":32050.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001567619-22-018466","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000156761922018466/doc1.xml","form_type":"4"}},{"id":2148562,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-01T01:31:04.000Z","date":"2022-09-28","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately four months and be forfeited to the extent it is not exercised on or prior to January 29, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately four months and be forfeited to the extent it is not exercised on or prior to January 29, 2023."}],"balance_after":20000,"derivative":{"exercise_price":6.41,"exercise_date":"2014-01-29","expiration_date":"2023-01-29","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001140361-22-035563","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000114036122035563/form4.xml","form_type":"4"}},{"id":2148561,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-10-01T01:31:04.000Z","date":"2022-09-28","kind":"sale","acquired":false,"shares":10000,"price":48.09,"value":480900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-22-035563","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000114036122035563/form4.xml","form_type":"4"}},{"id":2148560,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-10-01T01:31:04.000Z","date":"2022-09-28","kind":"exercise","acquired":true,"shares":10000,"price":6.41,"value":64100.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001140361-22-035563","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000114036122035563/form4.xml","form_type":"4"}},{"id":2203125,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-23T01:33:48.000Z","date":"2022-07-20","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately six months and be forfeited to the extent it is not exercised on or prior to January 29, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately six months and be forfeited to the extent it is not exercised on or prior to January 29, 2023."}],"balance_after":30000,"derivative":{"exercise_price":6.41,"exercise_date":"2014-01-29","expiration_date":"2023-01-29","underlying":"Ordinary Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001567619-22-014381","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000156761922014381/doc1.xml","form_type":"4"}},{"id":2203124,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-07-23T01:33:48.000Z","date":"2022-07-20","kind":"sale","acquired":false,"shares":15000,"price":32.9,"value":493500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-22-014381","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000156761922014381/doc1.xml","form_type":"4"}},{"id":2203123,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-07-23T01:33:48.000Z","date":"2022-07-20","kind":"exercise","acquired":true,"shares":15000,"price":6.41,"value":96150.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001567619-22-014381","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000156761922014381/doc1.xml","form_type":"4"}},{"id":2209679,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2022-07-08T20:18:37.000Z","date":"2022-07-07","kind":"grant","acquired":true,"shares":11554,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the stock option award vest and become exercisable in full on 7/7/2023."}],"balance_after":11554,"derivative":{"exercise_price":31.48,"exercise_date":"2023-07-07","expiration_date":"2032-07-07","underlying":"Ordinary Shares","underlying_shares":11554},"source":{"system":"sec-edgar","filing":"0001127602-22-019126","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760222019126/form4.xml","form_type":"4"}},{"id":2209678,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2022-07-08T20:18:37.000Z","date":"2022-07-07","kind":"grant","acquired":true,"shares":5957,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the restricted stock unit award vest in full on 7/7/2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares subject to the restricted stock unit award vest in full on 7/7/2023."}],"balance_after":5957,"derivative":{"exercise_date":"2023-07-07","underlying":"Ordinary Shares","underlying_shares":5957},"source":{"system":"sec-edgar","filing":"0001127602-22-019126","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760222019126/form4.xml","form_type":"4"}},{"id":2229578,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2022-06-16T20:54:22.000Z","date":"2022-06-14","kind":"exercise","acquired":false,"shares":7585,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award is fully vested in accordance with its terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award is fully vested in accordance with its terms."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7585},"source":{"system":"sec-edgar","filing":"0001127602-22-017634","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760222017634/form4.xml","form_type":"4"}},{"id":2229577,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2022-06-16T20:54:22.000Z","date":"2022-06-14","kind":"tax_withholding","acquired":false,"shares":3945,"price":27.19,"value":107264.55,"ownership":{"direct":true},"balance_after":94118,"source":{"system":"sec-edgar","filing":"0001127602-22-017634","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760222017634/form4.xml","form_type":"4"}},{"id":2229576,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2022-06-16T20:54:22.000Z","date":"2022-06-14","kind":"exercise","acquired":true,"shares":7585,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":98063,"source":{"system":"sec-edgar","filing":"0001127602-22-017634","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760222017634/form4.xml","form_type":"4"}},{"id":2252811,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-28T01:30:50.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2023 of the Issuer's shareholders, assuming continuous service as a director until such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":25.6,"expiration_date":"2032-05-18","underlying":"Ordinary Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001140361-22-021107","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000114036122021107/form4.xml","form_type":"4"}},{"id":2283834,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-05-03T20:56:45.000Z","date":"2022-05-02","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested in accordance with their terms."}],"balance_after":0,"derivative":{"exercise_price":16.55,"expiration_date":"2022-05-21","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001127602-22-013055","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760222013055/form4.xml","form_type":"4"}},{"id":2283833,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2022-05-03T20:56:45.000Z","date":"2022-05-02","kind":"sale","acquired":false,"shares":10000,"price":29.233,"value":292330.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.79 to $29.50. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":90478,"source":{"system":"sec-edgar","filing":"0001127602-22-013055","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760222013055/form4.xml","form_type":"4"}},{"id":2283832,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2022-05-03T20:56:45.000Z","date":"2022-05-02","kind":"exercise","acquired":true,"shares":10000,"price":16.55,"value":165500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":100478,"source":{"system":"sec-edgar","filing":"0001127602-22-013055","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760222013055/form4.xml","form_type":"4"}},{"id":2289487,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-04-27T20:29:48.000Z","date":"2022-04-25","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested in accordance with their terms."}],"balance_after":10000,"derivative":{"exercise_price":16.55,"expiration_date":"2022-05-21","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001127602-22-012571","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760222012571/form4.xml","form_type":"4"}},{"id":2289486,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2022-04-27T20:29:48.000Z","date":"2022-04-25","kind":"sale","acquired":false,"shares":10000,"price":27.8849,"value":278849.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.55 to $28.23. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":90478,"source":{"system":"sec-edgar","filing":"0001127602-22-012571","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760222012571/form4.xml","form_type":"4"}},{"id":2289485,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2022-04-27T20:29:48.000Z","date":"2022-04-25","kind":"exercise","acquired":true,"shares":10000,"price":16.55,"value":165500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":100478,"source":{"system":"sec-edgar","filing":"0001127602-22-012571","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760222012571/form4.xml","form_type":"4"}},{"id":2294552,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-04-19T20:26:34.000Z","date":"2022-04-18","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested in accordance with their terms."}],"balance_after":20000,"derivative":{"exercise_price":16.55,"expiration_date":"2022-05-21","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001127602-22-012147","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760222012147/form4.xml","form_type":"4"}},{"id":2294551,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2022-04-19T20:26:34.000Z","date":"2022-04-18","kind":"sale","acquired":false,"shares":10000,"price":28.875,"value":288750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.63 to $29.29. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":90478,"source":{"system":"sec-edgar","filing":"0001127602-22-012147","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760222012147/form4.xml","form_type":"4"}},{"id":2294550,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2022-04-19T20:26:34.000Z","date":"2022-04-18","kind":"exercise","acquired":true,"shares":10000,"price":16.55,"value":165500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":100478,"source":{"system":"sec-edgar","filing":"0001127602-22-012147","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760222012147/form4.xml","form_type":"4"}},{"id":2297558,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-14T01:45:20.000Z","date":"2022-04-11","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately 10 months and be forfeited to the extent it is not exercised on or prior to January 29, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately 10 months and be forfeited to the extent it is not exercised on or prior to January 29, 2023."}],"balance_after":45000,"derivative":{"exercise_price":6.41,"exercise_date":"2014-01-29","expiration_date":"2023-01-29","underlying":"Ordinary Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001567619-22-008508","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000156761922008508/doc1.xml","form_type":"4"}},{"id":2297557,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-04-14T01:45:20.000Z","date":"2022-04-11","kind":"sale","acquired":false,"shares":514,"price":36.5996,"value":18812.1944,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The transaction was executed in multiple trades in prices ranging from $36.40 to $36.83, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-22-008508","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000156761922008508/doc1.xml","form_type":"4"}},{"id":2297556,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-04-14T01:45:20.000Z","date":"2022-04-11","kind":"sale","acquired":false,"shares":1484,"price":35.7568,"value":53063.0912,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $35.40 to $36.34, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":514,"source":{"system":"sec-edgar","filing":"0001567619-22-008508","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000156761922008508/doc1.xml","form_type":"4"}},{"id":2297555,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-04-14T01:45:20.000Z","date":"2022-04-11","kind":"sale","acquired":false,"shares":3002,"price":34.4791,"value":103506.2582,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $34.21 to $35.09, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":1998,"source":{"system":"sec-edgar","filing":"0001567619-22-008508","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000156761922008508/doc1.xml","form_type":"4"}},{"id":2297554,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2022-04-14T01:45:20.000Z","date":"2022-04-11","kind":"exercise","acquired":true,"shares":5000,"price":6.41,"value":32050.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001567619-22-008508","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000156761922008508/doc1.xml","form_type":"4"}},{"id":2298231,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-04-12T20:54:51.000Z","date":"2022-04-11","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested in accordance with their terms."}],"balance_after":30000,"derivative":{"exercise_price":16.55,"expiration_date":"2022-05-21","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001127602-22-011911","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760222011911/form4.xml","form_type":"4"}},{"id":2298230,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2022-04-12T20:54:51.000Z","date":"2022-04-11","kind":"sale","acquired":false,"shares":10000,"price":29.2601,"value":292601.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.11 to $29.705. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":90478,"source":{"system":"sec-edgar","filing":"0001127602-22-011911","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760222011911/form4.xml","form_type":"4"}},{"id":2298229,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2022-04-12T20:54:51.000Z","date":"2022-04-11","kind":"exercise","acquired":true,"shares":10000,"price":16.55,"value":165500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":100478,"source":{"system":"sec-edgar","filing":"0001127602-22-011911","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760222011911/form4.xml","form_type":"4"}},{"id":2303652,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-04-06T00:45:40.000Z","date":"2022-04-04","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested in accordance with their terms."}],"balance_after":40000,"derivative":{"exercise_price":16.55,"expiration_date":"2022-05-21","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001127602-22-011644","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760222011644/form4.xml","form_type":"4"}},{"id":2303651,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2022-04-06T00:45:40.000Z","date":"2022-04-04","kind":"sale","acquired":false,"shares":10000,"price":28.1845,"value":281845.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.995 to $28.32. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":90478,"source":{"system":"sec-edgar","filing":"0001127602-22-011644","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760222011644/form4.xml","form_type":"4"}},{"id":2303650,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2022-04-06T00:45:40.000Z","date":"2022-04-04","kind":"exercise","acquired":true,"shares":10000,"price":16.55,"value":165500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":100478,"source":{"system":"sec-edgar","filing":"0001127602-22-011644","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760222011644/form4.xml","form_type":"4"}},{"id":2485095,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2021-12-04T02:11:44.000Z","date":"2021-12-02","kind":"exercise","acquired":false,"shares":5578,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award is fully vested in accordance with its terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award is fully vested in accordance with its terms."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5578},"source":{"system":"sec-edgar","filing":"0001127602-21-030297","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760221030297/form4.xml","form_type":"4"}},{"id":2485094,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2021-12-04T02:11:44.000Z","date":"2021-12-02","kind":"tax_withholding","acquired":false,"shares":2901,"price":22.11,"value":64141.11,"ownership":{"direct":true},"balance_after":90478,"source":{"system":"sec-edgar","filing":"0001127602-21-030297","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760221030297/form4.xml","form_type":"4"}},{"id":2485093,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2021-12-04T02:11:44.000Z","date":"2021-12-02","kind":"exercise","acquired":true,"shares":5578,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":93379,"source":{"system":"sec-edgar","filing":"0001127602-21-030297","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760221030297/form4.xml","form_type":"4"}},{"id":2665689,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2021-06-16T20:21:32.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":7585,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in full on 6/14/2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in full on 6/14/2022."}],"balance_after":7585,"derivative":{"exercise_date":"2022-06-14","underlying":"Ordinary Shares","underlying_shares":7585},"source":{"system":"sec-edgar","filing":"0001127602-21-020037","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760221020037/form4.xml","form_type":"4"}},{"id":2665688,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2021-06-16T20:21:32.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":15677,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the stock option award vest and become exercisable in full on 6/14/2022."}],"balance_after":15677,"derivative":{"exercise_price":24.72,"exercise_date":"2022-06-14","expiration_date":"2031-06-14","underlying":"Ordinary Shares","underlying_shares":15677},"source":{"system":"sec-edgar","filing":"0001127602-21-020037","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760221020037/form4.xml","form_type":"4"}},{"id":2667702,"issuer":{"id":124463,"kind":"organization","name":"Endo International plc","symbol":"ENDP"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-06-15T20:10:20.000Z","date":"2021-06-11","kind":"tax_withholding","acquired":false,"shares":24920,"price":6.26,"value":155999.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares represent ordinary shares withheld by Endo International plc to satisfy Mr. Cooke's tax withholding obligations on shares acquired on June 11, 2021."}],"balance_after":100034,"source":{"system":"sec-edgar","filing":"0001593034-21-000082","document":"wf-form4_162378779800867.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000159303421000082/wf-form4_162378779800867.xml","form_type":"4"}},{"id":2667701,"issuer":{"id":124463,"kind":"organization","name":"Endo International plc","symbol":"ENDP"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-06-15T20:10:20.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":47924,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These ordinary shares were granted to Mr. Cooke on June 11, 2021 in consideration of his services on Endo International plc's Board of Directors."}],"balance_after":124954,"source":{"system":"sec-edgar","filing":"0001593034-21-000082","document":"wf-form4_162378779800867.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000159303421000082/wf-form4_162378779800867.xml","form_type":"4"}},{"id":2700380,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-21T21:06:16.000Z","date":"2021-05-19","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2022 of the Issuer's shareholders, assuming continuous service as a director until such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":23.97,"expiration_date":"2031-05-19","underlying":"Ordinary Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001567619-21-010962","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1524823/000156761921010962/doc1.xml","form_type":"4"}},{"id":2700388,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2021-05-21T20:34:04.000Z","date":"2021-05-20","kind":"exercise","acquired":false,"shares":6104,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This restricted stock unit award vested in full on 5/20/2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This restricted stock unit award vested in full on 5/20/2021."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Ordinary Shares","underlying_shares":6104},"source":{"system":"sec-edgar","filing":"0001127602-21-017785","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760221017785/form4.xml","form_type":"4"}}],"next_cursor":"2021-05-21T20:34:04.000000Z,2700388"}